MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation. The gene discussed is MALT1; the disease is T-cell acute lymphoblastic leukemia.